Experience With Topical Acne Treatment
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Oct 12, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how well people can stick to using topical treatments for acne, which is a common skin condition that often requires multiple medications to manage. The study aims to understand why some patients start their acne treatment but then stop using it, as well as what might prevent them from starting in the first place. This is important because not following treatment can lead to worse skin problems and higher healthcare costs.
To participate in this trial, you must be an adult aged 18 or older, currently diagnosed with acne, and living in the United States. Participants will be asked questions about their experiences with acne treatments and may receive advice on how to improve their medication use. It's a chance to help researchers learn more about how to support patients like you in managing acne effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patients ≥18 years of age
- • 2. Patients with a current diagnosis of acne
- • 3. Patients who live in the US,
- • 4. Patients have sufficient command of the English language
- Exclusion Criteria:
- • 1. Patients less than the age of 18
- • 2. Patients without a current diagnosis of acne
- • 3. Patients who do not live in the US
- • 4. Patients without a sufficient command of the English language
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Steven R Feldman, MD, PhD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials